Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rita M La Rovere

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|May 19, 2017
Endoplasmic Reticulum-Mitochondrial Ca<sup>2+</sup> Fluxes Underlying Cancer Cell SurvivalHristina Ivanova, Martijn Kerkhofs, Rita M La Rovere, et al.
Advances in Experimental Medicine and Biology|March 30, 2018
IP<sub>3</sub> Receptor Properties and Function at Membrane Contact SitesGemma Roest, Rita M La Rovere, Geert Bultynck, et al.
Cell Calcium|July 15, 2017
Bcl-2 inhibitors as anti-cancer therapeutics: The impact of and on calcium signalingTamara Vervloessem, Martijn Kerkhofs, Rita M La Rovere, et al.
Cell Death Discovery|November 13, 2018
Extracellular and ER-stored Ca<sup>2+</sup> contribute to BIRD-2-induced cell death in diffuse large B-cell lymphoma cellsMart Bittremieux, Rita M La Rovere, Marleen Schuermans, et al.
The Journal of Biological Chemistry|February 15, 2015
The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondriaGiovanni Monaco, Elke Decrock, Nir Arbel, et al.
Cell Death & Disease|September 18, 2020
BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell modelsTamara Vervloessem, Binu K Sasi, Elena Xerxa, et al.
Cell Death and Differentiation|June 15, 2018
Constitutive IP<sub>3</sub> signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP<sub>3</sub> receptor disruptor BIRD-2Mart Bittremieux, Rita M La Rovere, Haidar Akl, et al.
Cell Reports|March 19, 2020
APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of ActomyosinSophie Uzureau, Laurence Lecordier, Pierrick Uzureau, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|May 19, 2017
Endoplasmic Reticulum-Mitochondrial Ca<sup>2+</sup> Fluxes Underlying Cancer Cell SurvivalHristina Ivanova, Martijn Kerkhofs, Rita M La Rovere, et al.
Advances in Experimental Medicine and Biology|March 30, 2018
IP<sub>3</sub> Receptor Properties and Function at Membrane Contact SitesGemma Roest, Rita M La Rovere, Geert Bultynck, et al.
Cell Calcium|July 15, 2017
Bcl-2 inhibitors as anti-cancer therapeutics: The impact of and on calcium signalingTamara Vervloessem, Martijn Kerkhofs, Rita M La Rovere, et al.
Cell Death Discovery|November 13, 2018
Extracellular and ER-stored Ca<sup>2+</sup> contribute to BIRD-2-induced cell death in diffuse large B-cell lymphoma cellsMart Bittremieux, Rita M La Rovere, Marleen Schuermans, et al.
The Journal of Biological Chemistry|February 15, 2015
The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondriaGiovanni Monaco, Elke Decrock, Nir Arbel, et al.
Cell Death & Disease|September 18, 2020
BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell modelsTamara Vervloessem, Binu K Sasi, Elena Xerxa, et al.
Cell Death and Differentiation|June 15, 2018
Constitutive IP<sub>3</sub> signaling underlies the sensitivity of B-cell cancers to the Bcl-2/IP<sub>3</sub> receptor disruptor BIRD-2Mart Bittremieux, Rita M La Rovere, Haidar Akl, et al.
Cell Reports|March 19, 2020
APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of ActomyosinSophie Uzureau, Laurence Lecordier, Pierrick Uzureau, et al.
Pageof 1